Single daily oral dose of gemfibrozil reduces postprandial hyperlipidemia in hyperlipidemic patients

Authors: Descamps O.; Hondekijn J.-C.; Godrie T.; Desager J.-P.; Heller F.R.

Source: Current Therapeutic Research, Volume 59, Number 8, August 1998 , pp. 545-555(11)

Publisher: Elsevier

Buy & download fulltext article:

This article is hosted on another website.

You may be required to register, activate a subscription or purchase the article before you can obtain the full text.

Proceed

Keywords: gemfibrozil; hyperlipidemia; postprandial hyperlipidemia; lipoprotein lipase; hepatic lipase

Language: English

Document Type: Research article

DOI: http://dx.doi.org/10.1016/S0011-393X(98)85094-7

Affiliations: 1: aTumor Metabolism Study Group, Hopital de Jolimont, Haine Saint Paul, , Belgium

Publication date: 1998-08-01

Related content

Tools

Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content

Text size:

A | A | A | A
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages. print icon Print this page